Search Results - "MARI, Davide"

Pharmacogenetic Profiling and Clinical Outcome of Patients With Advanced Gastric Cancer Treated With Palliative Chemotherapy by RUZZO, Annamaria, GRAZIANO, Francesco, MARI, Davide, TESTA, Enrica, SILVA, Rosarita, VINCENZI, Bruno, GIORDANI, Paolo, CASCINU, Stefano, GIUSTINI, Lucio, TONINI, Giuseppe, MAGNANI, Mauro, KAWAKAMI, Kazuyuki, WATANABE, Go, SANTINI, Daniele, CATALANO, Vincenzo, BISONNI, Renato, CANESTRARI, Emanuele, FICARELLI, Rita, MENICHETTI, Ettore Tito

“…To investigate whether polymorphisms with putative influence on fluorouracil/cisplatin activity are associated with clinical outcomes of patients with advanced…”
Get full text

Prognostic Analysis of E-Cadherin Gene Promoter Hypermethylation in Patients with Surgically Resected, Node-Positive, Diffuse Gastric Cancer by GRAZIANO, Francesco, ARDUINI, Federica, MARI, Davide, MAGNANI, Mauro, CASCINU, Stefano, RUZZO, Annamaria, BEARZI, Italo, HUMAR, Bostjan, MORE, Helen, SILVA, Rosarita, MURETTO, Pietro, GUILFORD, Parry, TESTA, Enrica

“…Purpose: Recent investigations have demonstrated that hypermethylation is a frequent mechanism for silencing tumor suppressor genes. This is a potentially…”
Get full text

Polymorphisms in genes involved in DNA repair and metabolism of xenobiotics in individual susceptibility to sporadic diffuse gastric cancer by Ruzzo, Annamaria, Canestrari, Emanuele, Maltese, Paolo, Pizzagalli, Francesca, Graziano, Francesco, Santini, Daniele, Catalano, Vincenzo, Ficarelli, Rita, Mari, Davide, Bisonni, Renato, Giordani, Paolo, Giustini, Lucio, Lippe, Paolo, Silva, Rosarita, Mattioli, Rodolfo, Torresi, Umberto, Latini, Luciano, Magnani, Mauro

“…Gastric cancer is the second highest cause of cancer mortality in the world, despite declining rates of incidence in many industrialized countries. We carried…”
Get more information

Methylenetetrahydrofolate reductase 677C/T gene polymorphism, gastric cancer susceptibility and genomic DNA hypomethylation in an at‐risk Italian population by Graziano, Francesco, Kawakami, Kazuyuki, Ruzzo, Annamaria, Watanabe, Go, Santini, Daniele, Pizzagalli, Francesca, Bisonni, Renato, Mari, Davide, Floriani, Irene, Catalano, Vincenzo, Silva, Rosarita, Tonini, Giuseppe, Torri, Valter, Giustini, Lucio, Magnani, Mauro

“…We performed a case‐control study to examine the relationship between MTHFR C677T gene polymorphism (MTHFR677C/T) and gastric cancer susceptibility in at‐risk…”
Get full text

Phase II study of pharmacogenetic-tailored therapy in elderly colorectal cancer patients by Scartozzi, Mario, Loretelli, Cristian, Berardi, Rossana, Pierantoni, Chiara, Silva, Rosa Rita, Mari, Davide, Giampieri, Riccardo, Faloppi, Luca, Pistelli, Mirco, Maccaroni, Elena, Bittoni, Alessandro, Del Prete, Michela, Galizia, Eva, Cascinu, Stefano

“…Abstract Background Retrospective analyses suggested that a pharmacogenetic approach may allow a tailored selection of chemotherapy for metastatic colorectal…”
Get full text

Elderly patients with advanced colorectal cancer: tolerability and activity of chemotherapy by Berardi, Rossana, Saladino, Tiziana, Mari, Davide, Silva, Rosa Rita, Scartozzi, Mario, Verdecchia, Lorena, Onofri, Azzurra, Cascinu, Stefano

“…Colorectal cancer is the most common gastrointestinal tumor in Western countries and is increasing in elderly patients. In recent years, new treatments based…”
Get full text

Predictive and prognostic role of E-cadherin protein expression in patients with advanced gastric carcinomas treated with palliative chemotherapy by Graziano, Francesco, Mandolesi, Alessandra, Ruzzo, Annamaria, Bearzi, Italo, Testa, Enrica, Arduini, Federica, Silva, Rosarita, Muretto, Pietro, Mari, Davide, Berardi, Rossana, Scartozzi, Mario, Lai, Vittorio, Cascinu, Stefano, Magnani, Mauro

“…Loss of E-cadherin expression has been related with an adverse outcome in patients with resected gastric cancer. More recently, experimental models with cancer…”
Get more information

A randomized, controlled phase III study of cyclophosphamide, doxorubicin, and vincristine with etoposide (CAV‐E) or teniposide (CAV‐T), followed by recombinant interferon‐α maintenance therapy or observation, in small cell lung carcinoma patients with complete responses by Tummarello, Diego, Mari, Davide, Graziano, Francesco, Isidori, Pierpaolo, Cetto, Gianluigi, Pasini, Felice, Santo, Antonio, Cellerino, Riccardo

“…BACKGROUND Studies of chemotherapy for patients with small cell lung carcinoma (SCLC) have shown that teniposide (T) may have higher activity than etoposide…”
Get full text

A randomized, controlled phase III study of cyclophosphamide, doxorubicin, and vincristine with etoposide (CAV-E) or teniposide (CAV-T), followed by recombinant interferon-? maintenance therapy or observation, in small cell lung carcinoma patients with complete responses by Tummarello, Diego, Mari, Davide, Graziano, Francesco, Isidori, Pierpaolo, Cetto, Gianluigi, Pasini, Felice, Santo, Antonio, Cellerino, Riccardo

Get full text

First line chemotherapy in patients with brain metastases from non-small and small cell lung cancer by Tummarello, D, Lippe, P, Bracci, R, Mari, D, Monterubbianesi, M C, Battelli, N

“…In this study we evaluated the role of systemic chemotherapy in 23 previously untreated patients with brain metastases from both non-small cell lung cancer…”
Get more information